Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery.

Background High levels of serum uric acid have been associated with adverse outcomes in cardiovascular diseases such as myocardial infarction and heart failure. The aim of the current study was to evaluate the prognostic role of serum uric acid levels in patients undergoing cardiac rehabilitation after myocardial revascularization and/or cardiac valve surgery. Design We performed an observational prospective cohort study. Methods The study included 1440 patients with available serum uric acid levels, prospectively followed for 5017 months. Mean age was 6711 years; 781 patients (54%) underwent myocardial revascularization, 474 (33%) cardiac valve surgery and 185 (13%) valve-plus-coronary artery by-pass graft surgery. The primary endpoints were overall and cardiovascular mortality while secondary end-points were combined major adverse cardiac and cerebrovascular events. Results Serum uric acid level mean values were 286 +/- 95 mu mol/l and elevated serum uric acid levels (360 mu mol/l or 6mg/dl) were found in 275 patients (19%). Overall mortality (hazard ratio=2.1; 95% confidence interval: 1.5-3.0; p<0.001), cardiovascular mortality (hazard ratio=2.0; 95% confidence interval: 1.2-3.2; p=0.004) and major adverse cardiac and cerebrovascular events rate (hazard ratio=1.5; 95% confidence interval: 1.0-2.0; p=0.019) were significantly higher in patients with elevated serum uric acid levels, even after adjustment for age, gender, arterial hypertension, diabetes, glomerular filtration rate, atrial fibrillation and medical therapy. Moreover, strong positive correlations between serum uric acid level and probability of overall mortality (p<0.001), cardiovascular mortality (p<0.001) and major adverse cardiac and cerebrovascular events (p=0.003) were found. Conclusions Serum uric acid levels predict mortality and adverse cardiovascular outcome in patients undergoing myocardial revascularization and/or cardiac valve surgery even after the adjustment for age, gender, arterial hypertension, diabetes, glomerular filtration rate and medical therapy.